Cohort

Company’s recent recruitment strategy change has resulted in an unprecedented level of inquiries regarding potential study participationTransplantation of islets into the enhanced…

Not too long ago, the MYHackathon 2022 concluded its first cohort, and five winners were chosen. The winners, which consist of technopreneurs, innovators, and subject-matter experts, were…

Atrasentan was well-tolerated with no treatment-related serious adverse events (SAEs) Atrasentan demonstrated mean proteinuria reductions of 38.1% proteinuria at six weeks of treatment,…

Kitchener, ON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Earlier this year the Medical Innovation Xchange (MIX) announced an innovative partnership with the Ontario Ministry of Labour,…

In a study using specialized imaging techniques, Johns Hopkins Medicine researchers report distinctive changes in the "white matter" and other brain tissue physiology of those with…

NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation…

Two-week survival in Cohort 4 (all-oral regimen) was 95% in 40 patients receiving MAT2203   Mean Early Fungicidal Activity (EFA) of the rate of yeast clearance in cerebrospinal fluid…

•  No safety concerns noted in ongoing clinical trial•  Study timeline remains on track MALVERN, Pa., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…

NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Big Idea Ventures, global leader in early-stage investments in the alternative protein sector, revealed its latest accelerator cohort…

IRVINE, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of…